Ladiratuzumab

Vendor: Abmole

Type: Antibodies

SKU: M24755

$207.00 USD
Shipping calculated at checkout.

Documents

Coa

Available in stock (500)

  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.

Product Overview

Bioactivity
Ladiratuzumab (hLIV22) is an anti-LIV-1/ZIP6 humanized monoclonal antibody. Ladiratuzumab, conjugated with the microtubule disrupting agent, MMAE to compose SGN-LIV1A, an antibody-drug conjugate (ADC). Ladiratuzumab can be used for research of breast cancer.
Casnumber
1629760-28-6
Purity
≥99.0%
Target synonyms
hLIV22
Ladiratuzumab

Ladiratuzumab

$207.00 USD